10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
In this matter, plaintiff Marisco Ltd. hired defendant GL Engineering & Construction (GL E&C) to con...
Read More >
In 2021, we bring you an overview of European competition news. In collaboration with our European o...
Read More >
• A payment to a government official can take many forms. • The SEC charges bank for books and re...
Read More >
When you look at the problems of retirement plans, one that gets short shrift is coverage and that i...
Read More >
The lowered threshold for foreign direct investments into France will apply to non-EU and non-EEA in...
Read More >
On July 2, 2019, New Jersey joined Illinois, Nevada, New Mexico, New York City, and Oklahoma in enac...
Read More >